King Pharmaceuticals has decided to discontinue the manufacturing of Humatin (paromomycin sulfate) capsules. This decision is based on medical use, availability of generic alternatives, diminished market demand, and growing manufacturing and distribution costs. Humatin will remain available through pharmacies and wholesalers until current supplies are depleted and generic paromomycin will continue to be available from another manufacturer.
Humatin is indicated for acute and chronic intestinal amebiasis and as adjunctive therapy for the management of hepatic coma.
For more information call (800) 776-3637 or visit www.kingpharm.com.